Not provided
Not provided
Not provided
Not provided
Not provided
Accrual rate fell far below needed accrual rate.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Klinik Hirslanden, Zurich | OTHER |
| Manja Gideon Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients.
The observational study will examine different follow-up modalities for ovarian cancer patients with the ultimate goal of improving follow-up strategies for an improved well-being and better clinical outcomes. The primary objective is to quantify the effects of conservative clinical diagnostics by collecting symptoms via ePRO in addition to intensive diagnostics (CA-125 testing, imaging diagnostics) during follow-up, on survival, time to clinical recurrence and well-being.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mobile app ovarian cancer followup (ePRO) | Device | The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients. |
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival three years after end of therapy | Overall survival three years after the end of primary therapy / start of follow-up | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Time to Recurrence | Time to Recurrence | 3 years |
| Total number of tumor relapses | Total number of tumor relapses occurring in the follow-up period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Patients whose compliance must be questioned, e.g. due to a psychiatric disorder, private life situation or insufficient knowledge on smartphone use and do not have a suitable caregiver to assist them with symptom reporting.
Not provided
Not provided
Not provided
Women ≥ 18 years old with a primary ovarian cancer diagnosis.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pius Wyss, Prof.Dr.med | Swiss Tumor Institue | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Spital Limmattal Frauenklinik | Schlieren | Canton of Zurich | 8952 | Switzerland | ||
| Gynäkologische Onkologie Spital Zollikerberg |
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 years |
| Well-being | Well-being according to the ECOG Performance Status GRADE ECOG PERFORMANCE STATUS 0 Fully active, able to carry on all pre-disease performance without restriction
| 3 years |
| Amount and frequency of patient data entries | Amount and frequency of patient data entries | 3 years |
| Platinum-sensitivity and the patients' platinum free interval (PFI) | Platinum-sensitivity and the patients' platinum free interval (PFI) | 3 years |
| Number and type of unplanned hospitalizations and emergencies. | Unplanned hospitalizations and emergencies are defined as additional consultations outside of planned therapy or control visits at the treatment center or with the investigator, as well as unplanned visits to other physicians (e.g., GP) or emergency services. | 3 years |
| Symptoms that led to further diagnostic measures and possibly the detection of tumor relapse | Symptoms that led to further diagnostic measures (imaging diagnostics and CA-125 testing) and possibly the detection of tumor relapse | 3 years |
| Zollikerberg |
| Canton of Zurich |
| 8125 |
| Switzerland |
| Praxis für Gynäkologie und Geburtshilfe | Zurich | 8002 | Switzerland |
| Interdisziplinäre Medizin Zürich (IMZ) | Zurich | 8008 | Switzerland |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |